Invesco
BCYC

Invesco’s Bicycle Therapeutics BCYC Stock Holding History

Invesco’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.9K Buy
15,067
+4,975
+49% +$28.4K ﹤0.01% 3664
2025
Q4 		$71.5K Buy
+10,092
New +$74.4K ﹤0.01% 3672

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco's BCYC Position: Q1 2026 in Review

Invesco increased its Bicycle Therapeutics (BCYC) stake by 49% in Q1 2026, buying an estimated $28.4K and bringing the position to 15,067 shares worth $69.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

Invesco first reported a position in BCYC in Q4 2025 and has held it in 2 quarters since. The position peaked at $71.5K in Q4 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Invesco held 15,067 shares of Bicycle Therapeutics worth $69.9K as of Q1 2026.
  • Invesco bought 4,975 Bicycle Therapeutics shares in Q1 2026, an estimated $28.4K.
  • Bicycle Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3664 holding.
  • Invesco first reported a position in Bicycle Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Invesco's Bicycle Therapeutics position peaked at $71.5K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.